# A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

> **NCT01611883** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 152 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01611883
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-02
- **Primary completion:** 2014-01-16
- **Final completion:** 2014-01-16
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611883, "A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01611883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*